Results 21 to 30 of about 14,935 (222)

Relationship between intact HIV-1 proviruses in circulating CD4+ T cells and rebound viruses emerging during treatment interruption. [PDF]

open access: yes, 2018
Combination antiretroviral therapy controls but does not cure HIV-1 infection because a small fraction of cells harbor latent viruses that can produce rebound viremia when therapy is interrupted. The circulating latent virus reservoir has been documented
Barton, John   +13 more
core   +1 more source

Normal chemotactic activity of granulocytes obtained by filtration leucapheresis [PDF]

open access: yes, 1977
The chemotactic activity of granulocytes obtained by the Terumo Filtration Leucapheresis System (F.L.) was examined by the method of Boyden's chamber. The number of cells migrating through the Millipore filter was expressed as the chemotactic activity ...
Kimura, Ikuro   +6 more
core   +1 more source

Current Challenges in Providing Good Leukapheresis Products for Manufacturing of CAR-T Cells for Patients with Relapsed/Refractory NHL or ALL

open access: yesCells, 2020
Background: T lymphocyte collection through leukapheresis is an essential step for chimeric antigen receptor T (CAR-T) cell therapy. Timing of apheresis is challenging in heavily pretreated patients who suffer from rapid progressive disease and receive T
Felix Korell   +11 more
doaj   +1 more source

Acute vision loss due to CML leukemic retinopathy reversed with leukapheresis

open access: yesClinical Case Reports, 2023
Leukemic retinopathy is a severe complication of severe leukocytosis that results from untreated chronic myelogenous leukemia (CML). Immediate cytoreduction via leukapheresis may reverse ocular manifestations and prevent permanent vision damage.
Sally Leong   +3 more
doaj   +1 more source

Improved collection of hematopoietic stem cells and progenitors from Fanconi anemia patients for gene therapy purposes

open access: yesMolecular Therapy: Methods & Clinical Development, 2021
Difficulties in the collection of hematopoietic stem and progenitor cells (HSPCs) from Fanconi anemia (FA) patients have limited the gene therapy in this disease.
Julián Sevilla   +29 more
doaj   +1 more source

Activated lymphocyte recruitment into the tumor microenvironment following preoperative sipuleucel-T for localized prostate cancer. [PDF]

open access: yes, 2014
BackgroundSipuleucel-T is a US Food and Drug Administration-approved immunotherapy for asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC). Its mechanism of action is not fully understood.
Amling, Christopher L   +12 more
core   +2 more sources

Bowel, lung, and retinal ischemia: Rare manifestations of leukostasis syndrome in a man with chronic lymphocytic leukemia—A case report and review of the literature

open access: yesCurrent Problems in Cancer: Case Reports, 2023
Leukapheresis is a resource-intensive and high-risk treatment with unclear benefits when used for leukostasis syndrome in hematologic malignancies.
Bowen He   +3 more
doaj   +1 more source

Leukapheresis and Granulocyte Transfusion

open access: yesCRC Critical Reviews in Clinical Laboratory Sciences, 1979
Granulocytes for transfusion can now be obtained from normal donors by one of four techniques that involve either centrifugation or reversible adhesion of granulocytes to nylon fibers. The leukapheresis process appears to be safe for donors and standards for the selection and care of donors are being formulated.
Jeffrey McCullough, Donald J. Higby
openaire   +3 more sources

Granulocyte and monocyte/macrophage apheresis for the treatment of immune-mediated inflammatory arthropathies: case reports

open access: yesDrugs in Context, 2021
Drug therapy of immune-mediated inflammatory arthropathies is not always satisfactory, and there is a risk of adverse events. Granulocyte and monocyte/macrophage apheresis (GMA) is a non-pharmacological therapeutic option that is beneficial and very well
Ana Victoria Carro Martínez   +2 more
doaj   +1 more source

Inhibition of MDR1 does not sensitize primitive chronic myeloid leukemia CD34+ cells to imatinib [PDF]

open access: yes, 2009
<p><b>Objective:</b> To investigate the interaction of imatinib mesylate (IM) with the clinically relevant adenosine triphosphate-binding cassette efflux transporter MDR1 (ABCB1) in cells from patients with chronic myeloid leukemia (CML)
Hatziieremia, S.   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy